Author pages are created from data sourced from our academic publisher partnerships and public sources.
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.
BACKGROUND We sought to provide a contemporary picture of the presentation, etiology, and outcome of infective endocarditis (IE) in a large patient cohort from multiple locations worldwide. METHODS… Expand
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee,…
BACKGROUND The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997. … Expand
Staphylococcus aureus endocarditis: a consequence of medical progress.
CONTEXT The global significance of infective endocarditis (IE) caused by Staphylococcus aureus is unknown. OBJECTIVES To document the international emergence of health care-associated S aureus IE… Expand
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
- V. Fowler, H. Boucher, +23 authors S. Cosgrove
- The New England journal of medicine
- 17 August 2006
BACKGROUND Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. METHODS We randomly assigned 124 patients with S. aureus bacteremia with or without endocarditis… Expand
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
BACKGROUND Complications of Staphylococcus aureus bacteremia (SAB) are often difficult to identify. The ability to accurately predict the likelihood of these complications would impact patient… Expand
Contemporary clinical profile and outcome of prosthetic valve endocarditis.
CONTEXT Prosthetic valve endocarditis (PVE) is associated with significant mortality and morbidity. The contemporary clinical profile and outcome of PVE are not well defined. OBJECTIVES To describe… Expand
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.
- B. Trichon, G. M. Felker, L. Shaw, C. Cabell, C. O'Connor
- The American journal of cardiology
- 1 March 2003
The goal of this study was to examine the frequency of mitral regurgitation (MR) in patients with left ventricular (LV) systolic dysfunction and to relate its presence and severity to long-term… Expand
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee,…
BACKGROUND The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis, which were last published in 1997. … Expand
Changing patient characteristics and the effect on mortality in endocarditis.
BACKGROUND Limited data exist on recent demographic and microbiological changes in infective endocarditis (IE) and the impact of these changes on patient survival. METHODS Data were collected from… Expand
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal…
- V. Fowler, G. Sakoulas, +11 authors A. Bayer
- The Journal of infectious diseases
- 15 September 2004
BACKGROUND The causes of persistent bacteremia (PB) due to methicillin-resistant Staphylococcus aureus (MRSA) are poorly understood. This investigation examined potential associations between PB with… Expand